the unmet needs in al amyloidosis and limitations of the current soc
Published 7 months ago • 73 plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
2:38
unmet needs in imaging for the diagnosis of al amyloidosis
-
0:47
unmet needs in amyloidosis treatment in the uk
-
0:45
unmet needs that remain for patients with al amyloidosis who fail frontline treatment
-
8:11
addressing unmet needs in the treatment of amyloidosis
-
1:00
unmet needs in al amyloidosis: treatment options for r/r patients
-
2:11
unmet needs and challenges in amyloidosis
-
2:47
key unmet needs that remain in frontline al amyloidosis
-
3:10
dr. chari discusses how he manages side effects related to talquetamab
-
4:42
what is the optimal place in the myeloma treatment algorithm for bispecifics?
-
4:52
an overview of al amyloidosis
-
1:34
are thrombotic risk and progression in et predictable?
-
2:50
unmet needs in amyloidosis
-
1:53
unmet needs in amyloidosis: early diagnosis, treating relapsed disease & progression criteria
-
5:14
current status & updates in the management of al amyloidosis
-
3:02
unmet needs in amyloidosis
-
2:11
an unmet need: reducing early death in amyloidosis
-
3:06
promising therapies under investigation for al amyloidosis: bispecifics, adcs, car-t cells & more
-
1:13
the unmet needs and future of cmml treatment
-
3:14
the impact of amyloid deposits in al amyloidosis
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:14
major unmet needs in amyloidosis: early diagnosis & addressing mechanisms of tissue damage
-
1:26
unmet needs that remain in stage 3b and r/r amyloidosis